CryoLife IPO, Regulatory and Securities Issues

CryoLife had a vision for developing implantable medical devices that would save lives. Steve Anderson, President and CEO, asked Arnall Golden Gregory how to grow his company and make it happen.

 Today, Steve’s idea is in the hearts of thousands of children.

Steve was convinced that he could make a difference in the wellness and spirit of the world. He came to Arnall Golden Gregory to find out how to structure and grow his life sciences company, CryoLife.

In addition to negotiating a successful IPO, AGG’s team has helped Steve work through the maze of regulatory, business and securities issues that many growing companies face. "AGG is a ’one stop shop‘ for growing companies," Steve offers. "As we grow and develop new technology to save lives, AGG’s creativity and personalized service allows us to move quickly and effectively."

Today, CryoLife is the leader in the development of tissue-engineered devices, grafts and adhesives. Their latest innovation, implantable heart valves, is literally saving the lives of thousands of children every year.



Printer Friendly FormatPrintEmail to a FriendEmail